Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2010 1
2011 1
2012 2
2014 2
2015 1
2016 1
2017 4
2018 1
2019 3
2020 3
2021 4
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 2 Esophagitis, CTCAE"
Page 1
The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.
de Jong C, Chargi N, Herder GJM, van Haarlem SWA, van der Meer F, van Lindert ASR, Ten Heuvel A, Brouwer J, de Jong PA, Devriese LA, Huitema ADR, Egberts TCG, de Bree R, Deneer VHM. de Jong C, et al. J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1554-1564. doi: 10.1002/jcsm.12967. Epub 2022 Mar 18. J Cachexia Sarcopenia Muscle. 2022. PMID: 35301821 Free PMC article.
RESULTS: In total, 297 patients (male n = 167, median age 64 years) were included. Haematological toxicity grade 3/4 was experienced in 36.6% (n = 108) of the patients, 24.6% (n = 73) experienced any non-haematological toxicity grade 2, and 55.6% (n = 165) an …
RESULTS: In total, 297 patients (male n = 167, median age 64 years) were included. Haematological toxicity grade 3/4 was experienced …
The efficacy and safety of definitive concurrent chemoradiotherapy for non-operable esophageal cancer.
Dreyfuss AD, Barsky AR, Wileyto EP, Eads JR, Kucharczuk JC, Williams NN, Karasic TB, Metz JM, Ben-Josef E, Plastaras JP, Wojcieszynski AP. Dreyfuss AD, et al. Cancer Med. 2021 Feb;10(4):1275-1288. doi: 10.1002/cam4.3724. Epub 2021 Jan 20. Cancer Med. 2021. PMID: 33474812 Free PMC article.
Most severe toxicities were acute grade 4 hematologic cytopenia (6%) and radiation dermatitis (1%). Most common acute grade 3 toxicities were hematologic cytopenia (35%), dysphagia (23%), and anorexia (19%). ...
Most severe toxicities were acute grade 4 hematologic cytopenia (6%) and radiation dermatitis (1%). Most common acute grade 3 …
Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer.
Bourbonne V, Da-Ano R, Jaouen V, Lucia F, Dissaux G, Bert J, Pradier O, Visvikis D, Hatt M, Schick U. Bourbonne V, et al. Radiother Oncol. 2021 Feb;155:144-150. doi: 10.1016/j.radonc.2020.10.040. Epub 2020 Nov 6. Radiother Oncol. 2021. PMID: 33161012
METHODS: Acute and late toxicities scored using the CTCAE v4.0 were retrospectively collected on patients treated with RT in our institution. ...DVH and usual clinical factors were also considered. Three toxicity prediction models (clinical only, clinical + DVH and …
METHODS: Acute and late toxicities scored using the CTCAE v4.0 were retrospectively collected on patients treated with RT in our inst …
Phase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer.
Lim TL, Pietrofesa RA, Arguiri E, Koumenis C, Feigenberg S, Simone CB 2nd, Rengan R, Cengel K, Levin WP, Christofidou-Solomidou M, Berman AT. Lim TL, et al. J Altern Complement Med. 2021 Oct;27(10):824-831. doi: 10.1089/acm.2020.0542. Epub 2021 Jun 23. J Altern Complement Med. 2021. PMID: 34161146 Clinical Trial.
The primary outcomes were overall adverse events, with particular focus on Grade 3 RP, and flaxseed tolerability. Adverse events were graded according to CTCAE v4.0. ...One patient (5%), with unverifiable flaxseed consumption, developed Grade 3 RP. The …
The primary outcomes were overall adverse events, with particular focus on Grade 3 RP, and flaxseed tolerability. Adverse events were …
Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer.
Nieder C, Imingen KS, Mannsåker B, Yobuta R, Haukland E. Nieder C, et al. Radiat Oncol. 2020 May 1;15(1):91. doi: 10.1186/s13014-020-01550-2. Radiat Oncol. 2020. PMID: 32357936 Free PMC article.
INCLUSION CRITERIA: prescribed total dose 30-54 Gy, dose per fraction 2.5-4 Gy, esophageal dose > 1 Gy. Uni- and multivariate analyses were performed in 97 eligible patients to identify predictive factors for acute esophagitis grade 1 (CTC …
INCLUSION CRITERIA: prescribed total dose 30-54 Gy, dose per fraction 2.5-4 Gy, esophageal dose > 1 Gy. Uni- and multivaria …
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study.
Ridolfi L, De Rosa F, Petracci E, Tanda ET, Marra E, Pigozzo J, Marconcini R, Guida M, Cappellini GCA, Gallizzi G, Occelli M, Pala L, Gambale E, Bersanelli M, Galdo G, Cortellini A, Morgese F, Zoratto F, Stucci LS, Strippoli S, Guidoboni M; Italian Melanoma Intergroup (IMI). Ridolfi L, et al. J Geriatr Oncol. 2020 Apr;11(3):515-522. doi: 10.1016/j.jgo.2019.12.012. Epub 2020 Jan 9. J Geriatr Oncol. 2020. PMID: 31928943
Clinical response was assessed using RECIST criteria and toxicity was evaluated according to CTCAE 4.0. Progression-free survival (PFS) and overall survival (OS) were estimated with the Kaplan-Meier method and the Cox model was used to assess potential prognostic fa …
Clinical response was assessed using RECIST criteria and toxicity was evaluated according to CTCAE 4.0. Progression-free survival (PF …
Evaluation of the early adverse effects of radiotherapy in breast cancer patients with COVID-19: Prospective single institutional study.
Allali S, Servois V, Beddok A, Fourquet A, Kirova Y. Allali S, et al. Breast J. 2021 Nov;27(11):824-827. doi: 10.1111/tbj.14282. Epub 2021 Aug 25. Breast J. 2021. PMID: 34435418 Free PMC article.
Radiotherapy (RT) consisted of breast or chest wall irradiation with or without lymph node irradiation, with protocols adapted to pandemic situation. The treatment-related toxicity was graded according to the CTCAE (version 4.03). All 350 patients treated for early- …
Radiotherapy (RT) consisted of breast or chest wall irradiation with or without lymph node irradiation, with protocols adapted to pandemic s …
Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study.
Yu WW, Zhu ZF, Fu XL, Zhao KL, Mao JF, Wu KL, Yang HJ, Fan M, Zhao S, Welsh J. Yu WW, et al. Strahlenther Onkol. 2014 Oct;190(11):979-86. doi: 10.1007/s00066-014-0636-y. Epub 2014 Mar 8. Strahlenther Onkol. 2014. PMID: 24609941 Clinical Trial.
The most common grade 2 and 3 radiation-related toxicity was radiation esophagitis, occurring in 64 % of all patients (but only 13 % as grade 3). No patient developed grade > 2 pulmonary complications. CONCLUSION: SIB-IMRT is a feasibl …
The most common grade 2 and 3 radiation-related toxicity was radiation esophagitis, occurring in 64 % of all patients ( …
Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction.
Bostel T, Nikolaidou E, Wollschläger D, Mayer A, Kaufmann J, Hopprich A, Rühle A, Grosu AL, Debus J, Fottner C, Moehler M, Grimminger P, Schmidberger H, Nicolay NH. Bostel T, et al. Radiat Oncol. 2024 Mar 4;19(1):28. doi: 10.1186/s13014-024-02414-9. Radiat Oncol. 2024. PMID: 38433231 Free PMC article.
Twenty-nine patients (34%) experienced higher-grade acute toxicities and 14 patients (16%) higher-grade late toxicities. ...Therefore, optimization of non-surgical approaches and the identification of potential predictive factors for safe administration of co …
Twenty-nine patients (34%) experienced higher-grade acute toxicities and 14 patients (16%) higher-grade late toxicities. ...Th …
Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus.
Münch S, Pigorsch SU, Feith M, Slotta-Huspenina J, Weichert W, Friess H, Combs SE, Habermehl D. Münch S, et al. Radiat Oncol. 2017 Nov 21;12(1):182. doi: 10.1186/s13014-017-0904-y. Radiat Oncol. 2017. PMID: 29157271 Free PMC article.
PATIENTS AND METHODS: We retrospectively compared 20 patients who were scheduled for nCRT with a total radiation dose of 41.4 Gy (daily dose of 1.8 Gy) and weekly chemotherapy with carboplatin (Area under the curve 2) and Paclitaxel (50 mg per square meter of body-surface …
PATIENTS AND METHODS: We retrospectively compared 20 patients who were scheduled for nCRT with a total radiation dose of 41.4 Gy (daily dose …
24 results